Time to seizure occurrence and damage in PROFILE, a multi-ethnic systemic lupus erythematosus cohort
暂无分享,去创建一个
M. Petri | G. Mcgwin | R. Ramsey‐Goldman | J. Reveille | R. Kimberly | G. Alarcon | J. Edberg | L. Vilá | G. Alarcón | G. McGwin | JC Edberg
[1] I. Bruce,et al. Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: an international inception cohort study. , 2007, Arthritis and rheumatism.
[2] D. Dlugos,et al. Role of genetics in the diagnosis and treatment of epilepsy , 2006, Expert review of neurotherapeutics.
[3] Gerald McGwin,et al. Time to Renal Disease and End-Stage Renal Disease in PROFILE: A Multiethnic Lupus Cohort , 2006, PLoS medicine.
[4] I. Scheffer,et al. De-novo mutations of the sodium channel gene SCN1A in alleged vaccine encephalopathy: a retrospective study , 2006, The Lancet Neurology.
[5] Marta E Alarcón-Riquelme,et al. A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus , 2006, Nature Genetics.
[6] R. Kimberly,et al. SLE: challenges and candidates in human disease. , 2005, Trends in immunology.
[7] R. Kimberly,et al. Genetics of susceptibility and severity in systemic lupus erythematosus , 2005, Current opinion in rheumatology.
[8] J. Mikdashi,et al. Factors at diagnosis predict subsequent occurrence of seizures in systemic lupus erythematosus , 2005, Neurology.
[9] A. Delgado-Escueta,et al. Sacred disease secrets revealed: the genetics of human epilepsy. , 2005, Human molecular genetics.
[10] J. Harley,et al. Genetics of human systemic lupus erythematosus: the emerging picture. , 2004, Current opinion in immunology.
[11] F. Cendes,et al. Epileptic seizures in systemic lupus erythematosus , 2004, Neurology.
[12] J. Hanly,et al. Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance. , 2004, The Journal of rheumatology.
[13] G. Hughes,et al. Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies. , 2003, The Journal of rheumatology.
[14] C. Langefeld,et al. Genetic linkage and association of Fcgamma receptor IIIA (CD16A) on chromosome 1q23 with human systemic lupus erythematosus. , 2002, Arthritis and rheumatism.
[15] W. Brooks,et al. The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus. , 2002, The Journal of rheumatology.
[16] G. Gronseth,et al. Neuropsychiatric syndromes in lupus: Prevalence using standardized definitions , 2002, Neurology.
[17] M. Petri,et al. Baseline characteristics of a multiethnic lupus cohort: PROFILE , 2002, Lupus.
[18] A. Auvinen,et al. Validity of the new American College of Rheumatology criteria for neuropsychiatric lupus syndromes: a population-based evaluation. , 2001, Arthritis and rheumatism.
[19] H. Bastian,et al. Sociocultural issues in clinical research. , 2001, Arthritis and rheumatism.
[20] D. Gladman,et al. The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index for Systemic Lupus Erythematosus International Comparison. , 2000, The Journal of rheumatology.
[21] J. Piette. Updating the American College of Rheumatology criteria for systemic lupus erythematosus: comment on the letter by Hochberg. , 1998, Arthritis and rheumatism.
[22] M. Hochberg,et al. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. , 1997, Arthritis and rheumatism.
[23] D. Symmons,et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. , 1996, Arthritis and rheumatism.
[24] J G Bodmer,et al. HLA class II region nucleotide sequences, 1995. , 1995, Tissue antigens.
[25] J G Bodmer,et al. HLA class II region nucleotide sequences. , 1995, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.
[26] C. Bombardier,et al. Sensitivity to change of 3 Systemic Lupus Erythematosus Disease Activity Indices: international validation. , 1994, The Journal of rheumatology.
[27] J. Reveille,et al. Association of amino acid sequences in the HLA-DQB1 first domain with antitopoisomerase I autoantibody response in scleroderma (progressive systemic sclerosis). , 1992, The Journal of clinical investigation.
[28] M. Liang,et al. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. , 1989, Arthritis and rheumatism.
[29] J F Fries,et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.